Technical Analysis for SNTI - Senti Biosciences, Inc.

Grade Last Price % Change Price Change
D 0.38 -3.31% -0.01
SNTI closed down 3.31 percent on Thursday, March 28, 2024, on 1.21 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
NR7 Range Contraction 0.00%
Fell Below 20 DMA Bearish -3.31%
Doji - Bullish? Reversal -3.31%
Gapped Down Weakness -3.31%
50 DMA Resistance Bearish -8.47%
Crossed Above 20 DMA Bullish -8.47%
Pocket Pivot Bullish Swing Setup -8.47%
Inside Day Range Contraction -8.47%
Fell Below 20 DMA Bearish -7.57%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 19 hours ago
2x Volume Pace about 21 hours ago
1.5x Volume Pace about 21 hours ago
Down 5% about 23 hours ago
Down 3% about 23 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Senti Biosciences, Inc. Description

Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. To accomplish this, we are building a synthetic biology platform that may enable us to program next-generation cell and gene therapies with what we refer to as Gene Circuits. These Gene Circuits, which are created from novel and proprietary combinations of DNA sequences, are designed to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We aim to design Gene Circuits to improve the intelligence of cell and gene therapies in order to enhance their therapeutic effectiveness, precision and durability against a broad range of diseases that conventional medicines do not readily address. Our synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells, outfitted with these Gene Circuit technologies, to target particularly challenging liquid and solid tumor oncology indications. Our lead programs include SENTI-202 and SENTI-301. SENTI-202 is a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate acute myeloid leukemia (AML) cells while sparing the healthy bone marrow. SENTI-301 is a Multi-Armed off-the-shelf CAR-NK cell therapy designed for the treatment of hepatocellular carcinoma (HCC). We anticipate filing Investigational New Drug (IND) applications in 2023 for both candidates. Over the past several months, Senti Bio scientists have presented preclinical proof-of-concept data across various programs including at the annual meetings of the American Society of Gene and Cell Therapy (ASGCT), the American Association for Cancer Research (AACR), and the American Society of Hematology (ASH). We have also demonstrated the breadth of our Gene Circuits in other modalities and diseases outside of oncology and have executed partnerships with Spark Therapeutics and BlueRock Therapeutics to advance these capabilities.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Disease Solid Tumors Immune System Emerging Technologies Cancer Immunotherapy Stem Cell Cell Therapy Acute Myeloid Leukemia Chimeric Antigen Receptor T Cell Hepatocellular Carcinoma Cancer Research Synthetic Biology

Is SNTI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.2162
52 Week Low 0.2701
Average Volume 85,618
200-Day Moving Average 0.53
50-Day Moving Average 0.42
20-Day Moving Average 0.40
10-Day Moving Average 0.41
Average True Range 0.05
RSI (14) 42.20
ADX 14.12
+DI 17.90
-DI 19.82
Chandelier Exit (Long, 3 ATRs) 0.36
Chandelier Exit (Short, 3 ATRs) 0.51
Upper Bollinger Bands 0.46
Lower Bollinger Band 0.35
Percent B (%b) 0.23
BandWidth 25.69
MACD Line -0.01
MACD Signal Line -0.01
MACD Histogram -0.0003
Fundamentals Value
Market Cap 16.8 Million
Num Shares 44.5 Million
EPS -1.96
Price-to-Earnings (P/E) Ratio -0.19
Price-to-Sales 7.38
Price-to-Book 0.23
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.43
Resistance 3 (R3) 0.43 0.41 0.42
Resistance 2 (R2) 0.41 0.40 0.41 0.42
Resistance 1 (R1) 0.39 0.39 0.39 0.39 0.42
Pivot Point 0.38 0.38 0.37 0.38 0.38
Support 1 (S1) 0.36 0.36 0.35 0.36 0.34
Support 2 (S2) 0.34 0.36 0.34 0.34
Support 3 (S3) 0.32 0.34 0.33
Support 4 (S4) 0.32